Crispr Infuses First Human in Landmark Gene-Editing Study

Crispr Therapeutics and partner Vertex Pharmaceuticals said on Monday morning that the first patient in a trial using CTX001 received the one-time medicine.

Comments

Popular posts from this blog

Garmin Instinct Crossover Solar With Up to 70 Days of Battery Life Launched in India: All Details

India’s Upcoming Digital Personal Data Protection Bill: Ten Things to Know About the Proposed Legislation